Bioaegis Therapeutics Inc.

This study tests whether an experimental drug called rhu-pGSN can reduce harmful inflammation caused by rapid decompression after high-pressure exposure. Thirty-six healthy, trained divers will be placed in a hyperbaric chamber to simulate a deep dive. Some will receive the drug …